Director, Global Commercial Strategy; Prostate Cancer

Marketing

Strategic Marketing

Professional

Raritan, New Jersey, United States of America

Johnson & Johnson Innovative Medicine is recruiting for a Director, Global Commercial Strategy (Prostate Cancer Early Development) in Raritan, NJ.

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at

This position is responsible for leading a potentially transformational molecule in clinical development for prostate cancer, supported by compelling early clinical data and advancing rapidly into registrational studies. As a strategically important growth opportunity within the global J&J prostate cancer portfolio, the asset has the potential to address significant unmet patient needs, establish a differentiated treatment paradigm and create substantial long-term value.

The Director, Global Commercial Strategy will serve as the commercial asset strategy lead for a clinical stage asset in Prostate Cancer, shaping the asset's indication-expansion, lifecycle-management, and data-generation strategies to maximize global patient impact and enterprise value. Working at the intersection of Commercial, Medical, Market Access, R&D and regional organizations, this leader will translate complex clinical, competitive and market insights into differentiated development priorities, compelling value propositions and robust commercial forecasts.

The role will influence critical investment and portfolio decisions, align global and regional stakeholders around an integrated compound strategy, and mobilize a broad cross-functional network to accelerate development, strengthen launch readiness and optimize the long-term value of the J&J prostate cancer portfolio.

• Own and lead the global commercial asset strategy for a clinical stage asset in Prostate Cancer across lifecycle and indication-expansion planning, and evidence-generation priorities, including the Integrated Evidence Generation Plan. Define the differentiated treatment opportunity and translate patient, customer and market needs into development choices that maximize launch potential, global adoption and long-term asset value.
• Lead enterprise-wide engagement with regional organizations to synthesize commercial, medical and market access insights into an integrated global compound strategy. Build alignment on priority indications, target-product profiles, evidence requirements and market-shaping investments while ensuring regional needs inform development and launch-readiness decisions.
• Co-create a cohesive compound-development and market-shaping strategy with Global Medical Affairs and Market Access leaders, integrating clinical, scientific, payer and customer perspectives. Anticipate evidence and access barriers, shape solutions early and ensure the asset's clinical program supports a compelling and differentiated value proposition.
• Direct cross-functional commercial assessments with Analytics, Finance, Competitive Intelligence and other partners to quantify opportunity, risk and strategic trade-offs. Develop differentiated value propositions, global forecasts and valuation scenarios that inform portfolio prioritization, governance discussions and investment decisions.
• Mobilize a broad matrix of partners, including R&D, Data Science, Supply Chain and launch-readiness functions, to convert strategy into disciplined execution. Establish clear priorities, decision points and accountabilities; resolve cross-functional issues; and deliver critical initiatives on time with measurable business impact.
• Perform other work-related duties as assigned.

The successful candidate will be a strategic, enterprise-minded leader who combines strong commercial judgment with scientific and clinical fluency. This individual must be able to influence senior stakeholders without direct authority, lead high-performing cross-functional teams and drive timely decisions in a complex, ambiguous and rapidly evolving environment. The role requires the ability to synthesize technical, clinical, regulatory, payer, competitive and market evidence…